NO20065661L - Indol-2-onderivater for behandling av sentralnerveforstyrrelser, gastrointestinale forstyrrelser og kardiovaskulaere forstyrrelser - Google Patents
Indol-2-onderivater for behandling av sentralnerveforstyrrelser, gastrointestinale forstyrrelser og kardiovaskulaere forstyrrelserInfo
- Publication number
- NO20065661L NO20065661L NO20065661A NO20065661A NO20065661L NO 20065661 L NO20065661 L NO 20065661L NO 20065661 A NO20065661 A NO 20065661A NO 20065661 A NO20065661 A NO 20065661A NO 20065661 L NO20065661 L NO 20065661L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- gastrointestinal
- central nervous
- indol
- treatment
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 206010029216 Nervousness Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- -1 3,3-disubstituted indol-2-one Chemical class 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400955A HU0400955D0 (en) | 2004-05-11 | 2004-05-11 | Pyridine derivatives of dialkyl oxindoles |
| HU0500463A HUP0500463A3 (en) | 2005-05-05 | 2005-05-05 | Pyridine derivatives of dialkyl-oxindoles |
| PCT/HU2005/000051 WO2005108390A1 (en) | 2004-05-11 | 2005-05-11 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065661L true NO20065661L (no) | 2007-02-08 |
Family
ID=89985998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065661A NO20065661L (no) | 2004-05-11 | 2006-12-06 | Indol-2-onderivater for behandling av sentralnerveforstyrrelser, gastrointestinale forstyrrelser og kardiovaskulaere forstyrrelser |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070232662A1 (es) |
| EP (1) | EP1751138B9 (es) |
| JP (1) | JP2007537228A (es) |
| KR (1) | KR20070014189A (es) |
| AT (1) | ATE382045T1 (es) |
| AU (1) | AU2005240844A1 (es) |
| BG (1) | BG109770A (es) |
| CA (1) | CA2566426A1 (es) |
| CZ (1) | CZ2006772A3 (es) |
| DE (1) | DE602005004024T2 (es) |
| EA (1) | EA010865B1 (es) |
| ES (1) | ES2299033T3 (es) |
| HR (2) | HRP20060403A2 (es) |
| IL (1) | IL179030A0 (es) |
| MX (1) | MXPA06013065A (es) |
| NO (1) | NO20065661L (es) |
| PL (2) | PL381614A1 (es) |
| PT (1) | PT1751138E (es) |
| RS (1) | RS20060622A (es) |
| SK (1) | SK51062006A3 (es) |
| WO (1) | WO2005108390A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007537229A (ja) * | 2004-05-11 | 2007-12-20 | エギシュ ヂョヂセルヂャール エンニュ・エル・テー | ジアルキルオキシインドールの新規なピペラジン誘導体 |
| RS20060619A (sr) * | 2004-05-11 | 2008-06-05 | Egis Gyogyszergyar Nyrt., | Piridinski derivati alkil oksindola kao aktivna sredstva koja deluju na 5-ht7 receptor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| US6407112B1 (en) * | 1998-04-22 | 2002-06-18 | Meiji Seika Kaisha, Ltd. | Optically active tetrahydrobenzindole derivative |
| FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
| AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
-
2005
- 2005-05-11 WO PCT/HU2005/000051 patent/WO2005108390A1/en active IP Right Grant
- 2005-05-11 SK SK5106-2006A patent/SK51062006A3/sk not_active Application Discontinuation
- 2005-05-11 PT PT05745439T patent/PT1751138E/pt unknown
- 2005-05-11 AT AT05745439T patent/ATE382045T1/de not_active IP Right Cessation
- 2005-05-11 CA CA002566426A patent/CA2566426A1/en not_active Abandoned
- 2005-05-11 CZ CZ20060772A patent/CZ2006772A3/cs unknown
- 2005-05-11 DE DE602005004024T patent/DE602005004024T2/de not_active Expired - Fee Related
- 2005-05-11 JP JP2007512358A patent/JP2007537228A/ja active Pending
- 2005-05-11 AU AU2005240844A patent/AU2005240844A1/en not_active Abandoned
- 2005-05-11 US US11/596,471 patent/US20070232662A1/en not_active Abandoned
- 2005-05-11 PL PL381614A patent/PL381614A1/pl not_active Application Discontinuation
- 2005-05-11 MX MXPA06013065A patent/MXPA06013065A/es active IP Right Grant
- 2005-05-11 KR KR1020067025313A patent/KR20070014189A/ko not_active Application Discontinuation
- 2005-05-11 RS RSP-2006/0622A patent/RS20060622A/sr unknown
- 2005-05-11 ES ES05745439T patent/ES2299033T3/es active Active
- 2005-05-11 EP EP05745439A patent/EP1751138B9/en active Active
- 2005-05-11 PL PL05745439T patent/PL1751138T3/pl unknown
- 2005-05-11 EA EA200602082A patent/EA010865B1/ru not_active IP Right Cessation
-
2006
- 2006-11-02 IL IL179030A patent/IL179030A0/en unknown
- 2006-11-20 HR HR20060403A patent/HRP20060403A2/xx not_active Application Discontinuation
- 2006-12-06 NO NO20065661A patent/NO20065661L/no not_active Application Discontinuation
- 2006-12-11 BG BG109770A patent/BG109770A/bg unknown
-
2008
- 2008-03-20 HR HR20080129T patent/HRP20080129T3/xx unknown
-
2009
- 2009-07-09 US US12/500,335 patent/US20090281137A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070014189A (ko) | 2007-01-31 |
| MXPA06013065A (es) | 2007-05-04 |
| AU2005240844A1 (en) | 2005-11-17 |
| PT1751138E (pt) | 2008-02-25 |
| DE602005004024T2 (de) | 2008-12-24 |
| HRP20080129T3 (en) | 2008-04-30 |
| DE602005004024D1 (de) | 2008-02-07 |
| EP1751138B1 (en) | 2007-12-26 |
| EA010865B1 (ru) | 2008-12-30 |
| PL1751138T3 (pl) | 2008-05-30 |
| JP2007537228A (ja) | 2007-12-20 |
| US20090281137A1 (en) | 2009-11-12 |
| ES2299033T3 (es) | 2008-05-16 |
| RS20060622A (en) | 2008-06-05 |
| HRP20060403A2 (en) | 2007-04-30 |
| EP1751138B9 (en) | 2008-11-12 |
| ATE382045T1 (de) | 2008-01-15 |
| CA2566426A1 (en) | 2005-11-17 |
| EA200602082A1 (ru) | 2007-04-27 |
| IL179030A0 (en) | 2007-03-08 |
| PL381614A1 (pl) | 2007-06-11 |
| CZ2006772A3 (cs) | 2007-03-14 |
| EP1751138A1 (en) | 2007-02-14 |
| WO2005108390A1 (en) | 2005-11-17 |
| US20070232662A1 (en) | 2007-10-04 |
| BG109770A (bg) | 2008-05-30 |
| SK51062006A3 (sk) | 2007-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO341591B1 (no) | 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt | |
| NO20061454L (no) | Compounds having CRTH2 antagonist activity | |
| NO20084489L (no) | Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet | |
| NO20070855L (no) | Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer. | |
| NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
| MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
| NO20071343L (no) | Substituerte fenylaminotiazoler og anvendelse derav | |
| NO20083562L (no) | Cannabinoidreseptormodulatorer | |
| NO20054082L (no) | Pyrazol`1,5-A! 1,3,5! triazinderivater som kannabinoidreseptorligander | |
| NO20060020L (no) | 3-fluorpiperidiner som NMDA/NR2B-antagonister | |
| NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| NO20073366L (no) | 1,6-substituert (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-2,5-piperazindionderivater som oksytocinreceptorantagonister for behandling av for tidlige veer, dysmenorri og endometriose | |
| NO20082511L (no) | Nye pyridopyraziner og deres anvendelse som kinasemodulatorer | |
| NO20071574L (no) | Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander. | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| NO20080445L (no) | Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer | |
| NO20051967L (no) | 3,4-disubstituerte pyroler og deres anvendelse ved behandling av inflammatoriske sykdommer. | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| ATE411981T1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| TW200732304A (en) | Piperidine derivatives | |
| DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
| NO20055517L (no) | 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler | |
| ATE524463T1 (de) | 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung | |
| NO20071466L (no) | 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |